Treatment of giant choledochal cysts with combined surgery and percutaneous transhepatic cholangial drainage: A case report

Table 1 Key hematological and biochemical parameters

Parameters
Hb%, 115-150 g/L	100 g/L
WBC, 3500-9500/cumm	9400/cumm
NE%, 40%-75%	87.2%
PLT, 150000-407000/cumm	719000/cumm
Serum creatinine, 39.0-76.0 μmol/L	77.9 μmol/L
Serum bilirubin (total), < 21.0 μmol/L	108.6 μmol/L
ALT, 6-29 U/L	102 U/L
ALK phosphates, 43-130 U/L	1083 U/L
PT, 9.4-12.5 seconds	15.0 seconds
ALB, 42.0-56.0 g/L	28.9 g/L
HBsAg, negative	Negative

Hb: Hemoglobin; WBC: White blood cell count; NE: Neutrophil; PLT: Platelet; ALT: Alanine aminotransferase; ALK: Alkaline; PT: Prothrombin time; ALB: Albumin; HBsAg: Hepatitis B surface antigen.

Table 2 Important hematological and biochemical parameters

Parameters
Bacterial + fungal culture	E. coli
PCT, 0.000-0.046 ng/mL	0.854 ng/mL
IL-6, 0.00-7.00 pg/mL	91.2 pg/mL
WBC, 3500-9500/cumm	13040/cumm
NE%, 40%-75%	81.37%
Hb%, 115-150 g/L	68 g/L
PLT, 150000-407000/cumm	334000/cumm

PCT: Procalcitonin; IL-6: Interleukin-6; WBC: White blood cell count; NE: Neutrophil; Hb: Hemoglobin; PLT: Platelet.

Table 3 Key hematological and biochemical parameters

Parameters
Hb%, 115-150 g/L	128 g/L
WBC, 3500-9500/cumm	5740/cumm
NE%, 40%-75%	84.10%
PLT, 150000-407000/cumm	267000/cumm
Serum creatinine, 39.0-76.0 μmol/L	43.9 μmol/L
Serum bilirubin (total), < 21.0 μmol/L	16.4 μmol/L
ALT, 6-29 U/L	59 U/L
ALK phosphates, 43-130 U/L	233 U/L
PT, 9.4-12.5 seconds	11.0 seconds
ALB, 42.0-56.0 g/L	39.2 g/L
HBsAg, negative	Negative

Hb: Hemoglobin; WBC: White blood cell count; NE: Neutrophil; PLT: Platelet; ALT: Alanine aminotransferase; ALK: Alkaline; PT: Prothrombin time; ALB: Albumin; HBsAg: Hepatitis B surface antigen.